![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial
Publisher: John Wiley & Sons Inc
E-ISSN: 1097-0045|75|11|1160-1166
ISSN: 0270-4137
Source: THE PROSTATE, Vol.75, Iss.11, 2015-08, pp. : 1160-1166
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)